These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34152818)

  • 21. Outbreak of colistin-resistant carbapenemase-producing Klebsiella pneumoniae in Tunisia.
    Mansour W; Haenni M; Saras E; Grami R; Mani Y; Ben Haj Khalifa A; El Atrouss S; Kheder M; Fekih Hassen M; Boujâafar N; Bouallegue O; Madec JY
    J Glob Antimicrob Resist; 2017 Sep; 10():88-94. PubMed ID: 28711559
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Outbreak of ESBL-producing Klebsiella pneumoniae in an Iranian Referral Hospital: Epidemiology and Molecular Typing.
    Mahmoudi S; Pourakbari B; Rahbarimanesh A; Abdosalehi MR; Ghadiri K; Mamishi S
    Infect Disord Drug Targets; 2019; 19(1):46-54. PubMed ID: 29732983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience.
    Veeraraghavan B; Shankar C; Karunasree S; Kumari S; Ravi R; Ralph R
    Pathog Glob Health; 2017 Jul; 111(5):240-246. PubMed ID: 28670975
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Occurrence of OXA-48 and NDM-1 carbapenemase-producing Klebsiella pneumoniae in a Moroccan university hospital in Casablanca, Morocco.
    Barguigua A; Zerouali K; Katfy K; El Otmani F; Timinouni M; Elmdaghri N
    Infect Genet Evol; 2015 Apr; 31():142-8. PubMed ID: 25620375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outbreak of KPC-2-Producing
    Su S; Li C; Zhao Y; Yu L; Wang Y; Wang Y; Bao M; Fu Y; Zhang J; Zhang X
    Microb Drug Resist; 2020 Sep; 26(9):1009-1018. PubMed ID: 32150494
    [No Abstract]   [Full Text] [Related]  

  • 26. Genotypes of Ciprofloxacin-Resistant Klebsiella pneumoniae in Korea and Their Characteristics According to the Genetic Lineages.
    Park DJ; Yu JK; Park KG; Park YJ
    Microb Drug Resist; 2015 Dec; 21(6):622-30. PubMed ID: 26207318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Emergence of clinical isolates of highly carbapenem-resistant Klebsiella pneumoniae co-harboring bla
    Sherchan JB; Tada T; Shrestha S; Uchida H; Hishinuma T; Morioka S; Shahi RK; Bhandari S; Twi RT; Kirikae T; Sherchand JB
    Int J Infect Dis; 2020 Mar; 92():247-252. PubMed ID: 31982619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Emerging high-risk ST101 and ST307 carbapenem-resistant Klebsiella pneumoniae clones from bloodstream infections in Southern Italy.
    Loconsole D; Accogli M; De Robertis AL; Capozzi L; Bianco A; Morea A; Mallamaci R; Quarto M; Parisi A; Chironna M
    Ann Clin Microbiol Antimicrob; 2020 Jun; 19(1):24. PubMed ID: 32487201
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Carbapenem-Resistant Klebsiella pneumoniae with Emphasis on New Delhi Metallo-Beta-Lactamase-1 (bla
    Shoja S; Ansari M; Faridi F; Azad M; Davoodian P; Javadpour S; Farahani A; Mobarrez BD; Karmostaji A
    Microb Drug Resist; 2018 May; 24(4):447-454. PubMed ID: 28972857
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Colistin resistance emerges in pandrug-resistant Klebsiella pneumoniae epidemic clones in Rio de Janeiro, Brazil.
    Longo LGA; de Sousa VS; Kraychete GB; Justo-da-Silva LH; Rocha JA; Superti SV; Bonelli RR; Martins IS; Moreira BM
    Int J Antimicrob Agents; 2019 Nov; 54(5):579-586. PubMed ID: 31479740
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antibiotic resistance and virulence characteristics analysis of a carbapenem-resistant hypervirulent
    Chen JW; Lu JY; Zhang R; Cai JC
    Zhonghua Yi Xue Za Zhi; 2021 Aug; 101(31):2478-2484. PubMed ID: 34399563
    [No Abstract]   [Full Text] [Related]  

  • 32. High-risk clones and novel sequence type ST4497 of Klebsiella pneumoniae clinical isolates producing different alleles of NDM-type and other carbapenemases from a single tertiary-care centre in Egypt.
    Gamal D; Egea P; Elías C; Fernández-Martínez M; Causse M; Pérez-Nadales E; Salem D; Fam N; Diab M; Aitta AA; El-Defrawy I; Martínez-Martínez L
    Int J Antimicrob Agents; 2020 Dec; 56(6):106164. PubMed ID: 32949764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring microevolution of OXA-48-producing Klebsiella pneumoniae ST147 in a hospital setting by SMRT sequencing.
    Zautner AE; Bunk B; Pfeifer Y; Spröer C; Reichard U; Eiffert H; Scheithauer S; Groß U; Overmann J; Bohne W
    J Antimicrob Chemother; 2017 Oct; 72(10):2737-2744. PubMed ID: 29091199
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dynamics and molecular features of OXA-48-like-producing Klebsiella pneumoniae lineages in a Tunisian hospital.
    Messaoudi A; Haenni M; Bouallègue O; Saras E; Chatre P; Chaouch C; Boujâafar N; Mansour W; Madec JY
    J Glob Antimicrob Resist; 2020 Mar; 20():87-93. PubMed ID: 31306816
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characterization of carbapenemase producing Klebsiella pneumoniae strains by multiplex PCR and PFGE methods: The first K.pneumoniae isolates co-producing OXA-48/KPC and KPC/NDM in Turkey.
    Genç S; Kolaylı F; Özçelik EY
    J Infect Chemother; 2022 Feb; 28(2):192-198. PubMed ID: 34711509
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection and molecular characterization of Escherichia coli CTX-M-15 and Klebsiella pneumoniae SHV-12 β-lactamases from bovine mastitis isolates in the United Kingdom.
    Timofte D; Maciuca IE; Evans NJ; Williams H; Wattret A; Fick JC; Williams NJ
    Antimicrob Agents Chemother; 2014; 58(2):789-94. PubMed ID: 24247146
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outbreak of KPC-2 Carbapenem-resistant Klebsiella pneumoniae ST76 and Carbapenem-resistant K2 Hypervirulent Klebsiella pneumoniae ST375 strains in Northeast China: molecular and virulent characteristics.
    Su S; Zhang J; Zhao Y; Yu L; Wang Y; Wang Y; Bao M; Fu Y; Li C; Zhang X
    BMC Infect Dis; 2020 Jul; 20(1):472. PubMed ID: 32616018
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of extended-spectrum beta-lactamase and carbapenemase-producing bloodstream isolates of Klebsiella pneumoniae in a tertiary care hospital.
    Abodakpi H; Chang KT; Sánchez Díaz AM; Cantón R; Lasco TM; Chan K; Sofjan AK; Tam VH
    J Chemother; 2018 Apr; 30(2):115-119. PubMed ID: 29125052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular epidemiology of NDM-1- and OXA-48-producing Klebsiella pneumoniae in an Iranian hospital: clonal dissemination of ST11 and ST893.
    Solgi H; Badmasti F; Giske CG; Aghamohammad S; Shahcheraghi F
    J Antimicrob Chemother; 2018 Jun; 73(6):1517-1524. PubMed ID: 29518198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of carbapenemases, ESBLs, and plasmid-mediated quinolone determinants in carbapenem-insensitive Escherichia coli and Klebsiella pneumoniae in Riyadh hospitals.
    Al-Agamy MH; Aljallal A; Radwan HH; Shibl AM
    J Infect Public Health; 2018; 11(1):64-68. PubMed ID: 28462854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.